Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

VisEn Medical Inc.

Apr 2007
VisEn Medical Inc. of Woburn, Mass., has announced a research collaboration with Merck & Co. Inc. of Whitehouse Station, N.J. Under the terms of the agreement, the partners will develop biomarkers for Merck to use in its drug discovery programs to study disease progression and therapeutic response. Fluorescence molecular tomography systems from VisEn will be used for analysis. The Massachusetts company also will commercialize technologies resulting from the partnership.

biomarkersBiophotonicsFluorescence molecular tomography systemsNews & FeaturesVisEn Medical Inc.

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.